(Q45268288)

English

Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in type 1 (insulin-dependent) diabetic patients

scientific article published in November 1989

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in type 1 (insulin-dependent) diabetic patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

1 reference

based on heuristic

inferred from title

author name string

A J Scheen

1

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

J Gillet

2

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

J Rosenthaler

3

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

J Guiot

4

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

P Henrivaux

5

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

B Jandrain

6

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

P J Lefèbvre

7

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

publication date

1 November 1989

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

801-809

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

https://scigraph.springernature.com/pub.10.1007/bf00264911

0 references

Microdetermination of long-chain fatty acids in plasma and tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postprandial effects of SMS 201-995 on gut hormones and glucose tolerance

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemistry and pharmacology of SMS 201-995, a long-acting octapeptide analogue of somatostatin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new method for determination of insulin-binding immunoglobulins in insulin-treated diabetic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Simple Method for the Determination of Serum Free Insulin Levels in Insulin-treated Patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac autonomic neuropathy in diabetes: comparison of measures of R-R interval variation

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic alterations after a two-hour nocturnal interruption of a continuous subcutaneous insulin infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of Somatostatin on Gastrointestinal Propagation and Absorption of Oral Glucose in Man

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Continuous subcutaneous insulin infusion in the treatment of diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood glucose control and the evolution of diabetic retinopathy and albuminuria. A preliminary multicenter trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Changes in hormonal counter-regulation following insulin-induced hypoglycemia with simultaneous administration of the somatostatin analog SMS 201-995]

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of hepatic fatty acid oxidation and ketone body production

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-insulin antibodies and metabolic deterioration after interruption of continuous subcutaneous insulin infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radioimmunological determination of human C-peptide in serum

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 1. Metabolic and hormonal consequences and scheme for a prompt return to adequate control

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dosage of hemoglobin A1c by isoelectrofocusing

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequency of diabetic ketoacidosis and hypoglycemic coma during treatment with continuous subcutaneous insulin infusion. Audit of medical care

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of systematic metabolic alterations after a one-hour interruption of continuous subcutaneous insulin infusion in type I diabetic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced postprandial hyperglycemia after subcutaneous injection of a somatostatin-analogue (SMS 201-995) in insulin-dependent diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of somatostatin and SMS 201-995 on carbohydrate metabolism in normal man

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

U-100 insulin gives some protection against metabolic deterioration due to CSII interruption

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocrine profile of a long-acting somatostatin derivative SMS 201-995. Study in normal volunteers following subcutaneous administration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute complications associated with insulin infusion pump therapy. Report of experience with 161 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 2. Marked attenuation of the metabolic deterioration by somatostatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of somatostatin analogue SMS 201-995 in normal man

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Physiological concentrations of growth hormone exert insulin-like and insulin antagonistic effects on both hepatic and extrahepatic tissues in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Continuous subcutaneous insulin infusion therapy. Prerequisites, indications and risks]

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The regulation of plasma ketone body concentration by counter-regulatory hormones in man. II. Effects of growth hormone in diabetic man

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin analog SMS 201-995 and insulin needs in insulin-dependent diabetic patients studied by means of an artificial pancreas

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetic ketoacidosis during long-term treatment with continuous subcutaneous insulin infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of SMS 201-995 in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/2687064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00264911

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45268288&oldid=2072224756"